Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL83

TAMOXIFEN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1

Basic Information

ChEMBL ID CHEMBL83
Name TAMOXIFEN
Phase Approved
Structure Type MOL
InChI Key NKANXQFJJICGDU-QPLCGJKRSA-N
Therapeutic ✓ Yes
Active Moiety CHEMBL4525767

Known Names

ICI-47699 Mammaton Novaldex NSC-727681 Tamoplex Tamoxifen Tamoxifene Tamoxifeno
111
Targets
475
Activities
4
Assay Types
12
PK Parameters
20
Publications
8
Known Names
20
Indications

Molecular Properties

371.5
MW (Da)
6.00
ALogP
2
HBA
0
HBD
12.5
PSA (Ų)
0.45
QED
1
Ro5 Violations
8
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1977
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning Prodrug
USAN Year 1976

Extended Properties

Molecular Formula C26H29NO
MW 371.52
Aromatic Rings 3
Heavy Atoms 28
NP-Likeness -0.40

Indications

Neoplasms Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms, Male Carcinoma, Intraductal, Noninfiltrating Cognitive Dysfunction Coronary Disease Fallopian Tube Neoplasms Hot Flashes Hyperplasia Hypertension Infertility Menopause Muscular Dystrophy, Duchenne Myocardial Ischemia Neoplasm Metastasis Ovarian Neoplasms Ovarian Neoplasms

ATC Classification

L02BA01
tamoxifen
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ENDOCRINE THERAPY

Activity Summary

IC50 395 meas. best 8.82
Ki 58 meas. best 9.29
EC50 21 meas. best 9.96
Kd 1 meas. best 9.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
MCF7
CHEMBL387
EC50 9.96 8.98 0.1 2
Estrogen receptor beta
CHEMBL242
Ki 9.29 9.29 0.5 1
Anti-estrogen binding site (AEBS)
CHEMBL612409
Kd 9.0 9.0 1.0 1
Estrogen receptor
CHEMBL206
IC50 8.82 6.7348 1.5 33
Emopamil-binding protein-like
CHEMBL2311238
Ki 8.55 8.55 2.8 1
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase
CHEMBL4931
Ki 8.3 8.3 5.0 1
Sigma non-opioid intracellular receptor 1
CHEMBL287
Ki 8.06 7.76 8.7 2
Estrogen receptor
CHEMBL2093866
Ki 7.92 7.3933 11.9 3
Anti-estrogen binding site (AEBS)
CHEMBL612409
IC50 7.92 7.92 12.0 1
MCF7
CHEMBL387
IC50 7.7 5.1915 20.0 110
Sigma non-opioid intracellular receptor 1
CHEMBL287
IC50 7.68 7.68 21.0 1
Estrogen receptor
CHEMBL206
Ki 7.51 7.51 31.2 1
Ishikawa
CHEMBL614649
EC50 7.48 7.48 33.0 1
MDA-MB-435
CHEMBL614697
IC50 7.3 7.15 50.0 2
Estrogen-related receptor gamma
CHEMBL4245
IC50 7.21 7.21 62.2 1
Estrogen receptor beta
CHEMBL242
IC50 7.1 6.5375 79.7 12
MDA-MB-231
CHEMBL400
IC50 7.1 4.7917 80.0 41
ATP-dependent translocase ABCB1
CHEMBL4302
Ki 7.0 7.0 100.0 1
Zaire ebolavirus
CHEMBL4513181
IC50 7.0 7.0 100.0 1
Progesterone receptor
CHEMBL208
IC50 6.89 6.89 128.8 1
Ishikawa
CHEMBL614649
IC50 6.77 5.1867 170.0 9
Cytochrome P450 3A4
CHEMBL340
Ki 6.7 6.7 200.0 1
Steroid hormone receptor ERR1
CHEMBL3429
IC50 6.7 6.7 200.0 1
5-hydroxytryptamine receptor 2C
CHEMBL225
Ki 6.62 6.62 241.0 1
Estrogen receptor
CHEMBL2093866
IC50 6.55 5.9989 280.0 9
D(3) dopamine receptor
CHEMBL234
Ki 6.44 6.44 364.0 1
Unchecked
CHEMBL612545
Ki 6.42 5.842 381.0 5
5-hydroxytryptamine receptor 2C
CHEMBL225
IC50 6.34 6.34 460.0 1
Unchecked
CHEMBL612545
IC50 6.3 5.2263 503.0 16
EL4
CHEMBL614293
IC50 6.27 6.27 535.0 1
Muscarinic acetylcholine receptor M3
CHEMBL245
Ki 6.2 6.2 630.0 1
Muscarinic acetylcholine receptor M4
CHEMBL1821
Ki 6.17 6.17 672.0 1
Muscarinic acetylcholine receptor M1
CHEMBL216
Ki 6.17 6.17 681.0 1
Alpha-2A adrenergic receptor
CHEMBL1867
Ki 6.14 6.14 726.0 1
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
Ki 6.1 6.1 792.2 1
Cytochrome P450 2B6
CHEMBL4729
Ki 6.05 6.05 900.0 1
Thromboxane-A synthase
CHEMBL1835
IC50 6.04 6.04 916.0 1
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
IC50 6.01 5.905 967.0 2
Protein kinase C (PKC)
CHEMBL2093867
IC50 6.0 5.35 1000.0 2
T47D
CHEMBL614361
IC50 6.0 5.0843 1000.0 7
5-hydroxytryptamine receptor 6
CHEMBL3371
Ki 5.98 5.945 1041.0 2
D(3) dopamine receptor
CHEMBL234
IC50 5.97 5.97 1072.0 1
Tyrosine-protein kinase Fyn
CHEMBL1841
IC50 5.92 5.92 1195.0 1
Sodium-dependent serotonin transporter
CHEMBL228
Ki 5.91 5.91 1240.0 1
Substance-K receptor
CHEMBL2327
Ki 5.91 5.91 1223.0 1
5-hydroxytryptamine receptor 2B
CHEMBL1833
Ki 5.88 5.88 1326.0 1
5-hydroxytryptamine receptor 2A
CHEMBL224
Ki 5.86 5.86 1372.0 1
Sodium-dependent noradrenaline transporter
CHEMBL222
Ki 5.84 5.84 1459.0 1
Sodium-dependent noradrenaline transporter
CHEMBL222
IC50 5.83 5.83 1472.0 1
Sodium-dependent dopamine transporter
CHEMBL238
Ki 5.83 5.83 1462.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC - - Mus musculus
CL - - Homo sapiens
CL - - Homo sapiens
CL 12.0 mL.min-1.kg-1 Homo sapiens
CL 33.0 mL.min-1.kg-1 Rattus norvegicus
CL 95.0 mL.min-1.kg-1 Rattus norvegicus
Cmax 296.0 nM Homo sapiens
F 69.0 % Rattus norvegicus
KA 2.1e-07 M -
t1/2 - - Homo sapiens
T1/2 0.1483 hr Mus musculus
T1/2 1.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
MCF7 EC50 = 0.11 nM 9.96 Effective dose for [3H]- estradiol against proliferation of MCF-7 cells 2769681
Estrogen receptor beta Ki = 0.51 nM 9.29 Displacement of [3H]estradiol from ERbeta after 4 hrs by scintillation counting 22582136
Anti-estrogen binding site (AEBS) Kd = 1.0 nM 9.0 Binding affinity towards antiestrogen binding site AEBS 12620065
Estrogen receptor IC50 = 1.5 nM 8.82 Inhibition of estrogen receptor-alpha (unknown origin) by ELISA 30731397
Emopamil-binding protein-like Ki = 2.8 nM 8.55 Binding affinity to emopamil binding protein (unknown origin) 23199475
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Ki = 5.0 nM 8.3 Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerev... 16033255
Estrogen receptor IC50 = 8.0 nM 8.1 Displacement of [3H]-E2 from human ER-alpha incubated for 16 to 20 hrs by liquid... 26896706
Estrogen receptor IC50 = 8.4 nM 8.08 Displacement of radioligand from Estrogen receptor alpha 11965371
Sigma non-opioid intracellular receptor 1 Ki = 8.714 nM 8.06 DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) -
MCF7 EC50 = 10.0 nM 8.0 Effective concentration against MCF-7 breast tumor cells using MCF-7 assay. 12825935
Estrogen receptor Ki = 11.9 nM 7.92 Inhibition of estradiol binding to estrogen receptor in Human Breast cancer cyto... 9216828
Anti-estrogen binding site (AEBS) IC50 = 12.0 nM 7.92 Displacement of [3H]tamoxifen from antiestrogen binding site (AEBS) 2909731
MCF7 IC50 = 20.0 nM 7.7 Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth meas... 33479633
Sigma non-opioid intracellular receptor 1 IC50 = 21.0 nM 7.68 DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) -
Estrogen receptor IC50 = 24.55 nM 7.61 Binding affinity to ERalpha receptor (unknown origin) 26407012
MCF7 IC50 = 27.0 nM 7.57 Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay 22472045
MCF7 IC50 = 30.0 nM 7.52 Antiproliferative activity against human MCF7 cells assessed as inhibition of ce... 33257172
Estrogen receptor Ki = 31.19 nM 7.51 Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells... 20621492
Ishikawa EC50 = 33.0 nM 7.48 Concentration of compound required to induce 50 % of the maximum stimulation of ... 8201587
Estrogen receptor Ki = 34.4 nM 7.46 Apparent inhibition constant for estrogen receptor in Human uterine cytosol in 3... 9216828

Literature References

Data from ChEMBL 36 via Core Engine